The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Rotavirus Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Rotavirus Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Rotavirus Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Adult accounting for % of the Rotavirus Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Rotarix segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Rotavirus Vaccines include Bharat Biotech, Merck & Co., Inc, GlaxoSmithKline plc, Lanzhou Institute of Biological, and Bharat Biotech International Limited, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Rotavirus Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
Market segment by Application can be divided into
Adult
Pediatric
The key market players for global Rotavirus Vaccines market are listed below:
Bharat Biotech
Merck & Co., Inc
GlaxoSmithKline plc
Lanzhou Institute of Biological
Bharat Biotech International Limited
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rotavirus Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Rotavirus Vaccines, with price, sales, revenue and global market share of Rotavirus Vaccines from 2019 to 2022.
Chapter 3, the Rotavirus Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rotavirus Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Rotavirus Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Rotavirus Vaccines.
Chapter 13, 14, and 15, to describe Rotavirus Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Rotavirus Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Rotavirus Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Adult accounting for % of the Rotavirus Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Rotarix segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Rotavirus Vaccines include Bharat Biotech, Merck & Co., Inc, GlaxoSmithKline plc, Lanzhou Institute of Biological, and Bharat Biotech International Limited, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Rotavirus Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
Market segment by Application can be divided into
Adult
Pediatric
The key market players for global Rotavirus Vaccines market are listed below:
Bharat Biotech
Merck & Co., Inc
GlaxoSmithKline plc
Lanzhou Institute of Biological
Bharat Biotech International Limited
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rotavirus Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Rotavirus Vaccines, with price, sales, revenue and global market share of Rotavirus Vaccines from 2019 to 2022.
Chapter 3, the Rotavirus Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rotavirus Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Rotavirus Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Rotavirus Vaccines.
Chapter 13, 14, and 15, to describe Rotavirus Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Rotavirus Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Rotavirus Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Rotarix
1.2.3 RotaTeq
1.2.4 Rotavac
1.2.5 Rotavin-M1
1.2.6 Lanzhou lamb
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Rotavirus Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Adult
1.3.3 Pediatric
1.4 Global Rotavirus Vaccines Market Size & Forecast
1.4.1 Global Rotavirus Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Rotavirus Vaccines Sales in Volume (2017-2028)
1.4.3 Global Rotavirus Vaccines Price (2017-2028)
1.5 Global Rotavirus Vaccines Production Capacity Analysis
1.5.1 Global Rotavirus Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Rotavirus Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Rotavirus Vaccines Market Drivers
1.6.2 Rotavirus Vaccines Market Restraints
1.6.3 Rotavirus Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Bharat Biotech
2.1.1 Bharat Biotech Details
2.1.2 Bharat Biotech Major Business
2.1.3 Bharat Biotech Rotavirus Vaccines Product and Services
2.1.4 Bharat Biotech Rotavirus Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck & Co., Inc
2.2.1 Merck & Co., Inc Details
2.2.2 Merck & Co., Inc Major Business
2.2.3 Merck & Co., Inc Rotavirus Vaccines Product and Services
2.2.4 Merck & Co., Inc Rotavirus Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 GlaxoSmithKline plc
2.3.1 GlaxoSmithKline plc Details
2.3.2 GlaxoSmithKline plc Major Business
2.3.3 GlaxoSmithKline plc Rotavirus Vaccines Product and Services
2.3.4 GlaxoSmithKline plc Rotavirus Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Lanzhou Institute of Biological
2.4.1 Lanzhou Institute of Biological Details
2.4.2 Lanzhou Institute of Biological Major Business
2.4.3 Lanzhou Institute of Biological Rotavirus Vaccines Product and Services
2.4.4 Lanzhou Institute of Biological Rotavirus Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bharat Biotech International Limited
2.5.1 Bharat Biotech International Limited Details
2.5.2 Bharat Biotech International Limited Major Business
2.5.3 Bharat Biotech International Limited Rotavirus Vaccines Product and Services
2.5.4 Bharat Biotech International Limited Rotavirus Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Rotavirus Vaccines Breakdown Data by Manufacturer
3.1 Global Rotavirus Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Rotavirus Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Rotavirus Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Rotavirus Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Rotavirus Vaccines Manufacturer Market Share in 2021
3.5 Global Rotavirus Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Rotavirus Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Rotavirus Vaccines Market Size by Region
4.1.1 Global Rotavirus Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Rotavirus Vaccines Revenue by Region (2017-2028)
4.2 North America Rotavirus Vaccines Revenue (2017-2028)
4.3 Europe Rotavirus Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Rotavirus Vaccines Revenue (2017-2028)
4.5 South America Rotavirus Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Rotavirus Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Rotavirus Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Rotavirus Vaccines Revenue by Type (2017-2028)
5.3 Global Rotavirus Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Rotavirus Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Rotavirus Vaccines Revenue by Application (2017-2028)
6.3 Global Rotavirus Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Rotavirus Vaccines Sales by Type (2017-2028)
7.2 North America Rotavirus Vaccines Sales by Application (2017-2028)
7.3 North America Rotavirus Vaccines Market Size by Country
7.3.1 North America Rotavirus Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Rotavirus Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Rotavirus Vaccines Sales by Type (2017-2028)
8.2 Europe Rotavirus Vaccines Sales by Application (2017-2028)
8.3 Europe Rotavirus Vaccines Market Size by Country
8.3.1 Europe Rotavirus Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Rotavirus Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Rotavirus Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Rotavirus Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Rotavirus Vaccines Market Size by Region
9.3.1 Asia-Pacific Rotavirus Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Rotavirus Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Rotavirus Vaccines Sales by Type (2017-2028)
10.2 South America Rotavirus Vaccines Sales by Application (2017-2028)
10.3 South America Rotavirus Vaccines Market Size by Country
10.3.1 South America Rotavirus Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Rotavirus Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Rotavirus Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Rotavirus Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Rotavirus Vaccines Market Size by Country
11.3.1 Middle East & Africa Rotavirus Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Rotavirus Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Rotavirus Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Rotavirus Vaccines
12.3 Rotavirus Vaccines Production Process
12.4 Rotavirus Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Rotavirus Vaccines Typical Distributors
13.3 Rotavirus Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Rotavirus Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Rotavirus Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 4. Bharat Biotech Major Business
Table 5. Bharat Biotech Rotavirus Vaccines Product and Services
Table 6. Bharat Biotech Rotavirus Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 8. Merck & Co., Inc Major Business
Table 9. Merck & Co., Inc Rotavirus Vaccines Product and Services
Table 10. Merck & Co., Inc Rotavirus Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 12. GlaxoSmithKline plc Major Business
Table 13. GlaxoSmithKline plc Rotavirus Vaccines Product and Services
Table 14. GlaxoSmithKline plc Rotavirus Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Lanzhou Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 16. Lanzhou Institute of Biological Major Business
Table 17. Lanzhou Institute of Biological Rotavirus Vaccines Product and Services
Table 18. Lanzhou Institute of Biological Rotavirus Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bharat Biotech International Limited Basic Information, Manufacturing Base and Competitors
Table 20. Bharat Biotech International Limited Major Business
Table 21. Bharat Biotech International Limited Rotavirus Vaccines Product and Services
Table 22. Bharat Biotech International Limited Rotavirus Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global Rotavirus Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 24. Global Rotavirus Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in Rotavirus Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global Rotavirus Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Rotavirus Vaccines Production Site of Key Manufacturer
Table 28. Rotavirus Vaccines New Entrant and Capacity Expansion Plans
Table 29. Rotavirus Vaccines Mergers & Acquisitions in the Past Five Years
Table 30. Global Rotavirus Vaccines Sales by Region (2017-2022) & (K Units)
Table 31. Global Rotavirus Vaccines Sales by Region (2023-2028) & (K Units)
Table 32. Global Rotavirus Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 33. Global Rotavirus Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 34. Global Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)
Table 35. Global Rotavirus Vaccines Sales by Type (2023-2028) & (K Units)
Table 36. Global Rotavirus Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 37. Global Rotavirus Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 38. Global Rotavirus Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 39. Global Rotavirus Vaccines Price by Type (2023-2028) & (USD/Unit)
Table 40. Global Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)
Table 41. Global Rotavirus Vaccines Sales by Application (2023-2028) & (K Units)
Table 42. Global Rotavirus Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 43. Global Rotavirus Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 44. Global Rotavirus Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 45. Global Rotavirus Vaccines Price by Application (2023-2028) & (USD/Unit)
Table 46. North America Rotavirus Vaccines Sales by Country (2017-2022) & (K Units)
Table 47. North America Rotavirus Vaccines Sales by Country (2023-2028) & (K Units)
Table 48. North America Rotavirus Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 49. North America Rotavirus Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 50. North America Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)
Table 51. North America Rotavirus Vaccines Sales by Type (2023-2028) & (K Units)
Table 52. North America Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)
Table 53. North America Rotavirus Vaccines Sales by Application (2023-2028) & (K Units)
Table 54. Europe Rotavirus Vaccines Sales by Country (2017-2022) & (K Units)
Table 55. Europe Rotavirus Vaccines Sales by Country (2023-2028) & (K Units)
Table 56. Europe Rotavirus Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe Rotavirus Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)
Table 59. Europe Rotavirus Vaccines Sales by Type (2023-2028) & (K Units)
Table 60. Europe Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)
Table 61. Europe Rotavirus Vaccines Sales by Application (2023-2028) & (K Units)
Table 62. Asia-Pacific Rotavirus Vaccines Sales by Region (2017-2022) & (K Units)
Table 63. Asia-Pacific Rotavirus Vaccines Sales by Region (2023-2028) & (K Units)
Table 64. Asia-Pacific Rotavirus Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific Rotavirus Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)
Table 67. Asia-Pacific Rotavirus Vaccines Sales by Type (2023-2028) & (K Units)
Table 68. Asia-Pacific Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)
Table 69. Asia-Pacific Rotavirus Vaccines Sales by Application (2023-2028) & (K Units)
Table 70. South America Rotavirus Vaccines Sales by Country (2017-2022) & (K Units)
Table 71. South America Rotavirus Vaccines Sales by Country (2023-2028) & (K Units)
Table 72. South America Rotavirus Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 73. South America Rotavirus Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 74. South America Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)
Table 75. South America Rotavirus Vaccines Sales by Type (2023-2028) & (K Units)
Table 76. South America Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)
Table 77. South America Rotavirus Vaccines Sales by Application (2023-2028) & (K Units)
Table 78. Middle East & Africa Rotavirus Vaccines Sales by Region (2017-2022) & (K Units)
Table 79. Middle East & Africa Rotavirus Vaccines Sales by Region (2023-2028) & (K Units)
Table 80. Middle East & Africa Rotavirus Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa Rotavirus Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)
Table 83. Middle East & Africa Rotavirus Vaccines Sales by Type (2023-2028) & (K Units)
Table 84. Middle East & Africa Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)
Table 85. Middle East & Africa Rotavirus Vaccines Sales by Application (2023-2028) & (K Units)
Table 86. Rotavirus Vaccines Raw Material
Table 87. Key Manufacturers of Rotavirus Vaccines Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Rotavirus Vaccines Typical Distributors
Table 91. Rotavirus Vaccines Typical Customers
List of Figures
Figure 1. Rotavirus Vaccines Picture
Figure 2. Global Rotavirus Vaccines Revenue Market Share by Type in 2021
Figure 3. Rotarix
Figure 4. RotaTeq
Figure 5. Rotavac
Figure 6. Rotavin-M1
Figure 7. Lanzhou lamb
Figure 8. Others
Figure 9. Global Rotavirus Vaccines Revenue Market Share by Application in 2021
Figure 10. Adult
Figure 11. Pediatric
Figure 12. Global Rotavirus Vaccines Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Rotavirus Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Rotavirus Vaccines Sales (2017-2028) & (K Units)
Figure 15. Global Rotavirus Vaccines Price (2017-2028) & (USD/Unit)
Figure 16. Global Rotavirus Vaccines Production Capacity (2017-2028) & (K Units)
Figure 17. Global Rotavirus Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Rotavirus Vaccines Market Drivers
Figure 19. Rotavirus Vaccines Market Restraints
Figure 20. Rotavirus Vaccines Market Trends
Figure 21. Global Rotavirus Vaccines Sales Market Share by Manufacturer in 2021
Figure 22. Global Rotavirus Vaccines Revenue Market Share by Manufacturer in 2021
Figure 23. Rotavirus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Rotavirus Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Rotavirus Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Rotavirus Vaccines Sales Market Share by Region (2017-2028)
Figure 27. Global Rotavirus Vaccines Revenue Market Share by Region (2017-2028)
Figure 28. North America Rotavirus Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. Europe Rotavirus Vaccines Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Rotavirus Vaccines Revenue (2017-2028) & (USD Million)
Figure 31. South America Rotavirus Vaccines Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Rotavirus Vaccines Revenue (2017-2028) & (USD Million)
Figure 33. Global Rotavirus Vaccines Sales Market Share by Type (2017-2028)
Figure 34. Global Rotavirus Vaccines Revenue Market Share by Type (2017-2028)
Figure 35. Global Rotavirus Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 36. Global Rotavirus Vaccines Sales Market Share by Application (2017-2028)
Figure 37. Global Rotavirus Vaccines Revenue Market Share by Application (2017-2028)
Figure 38. Global Rotavirus Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 39. North America Rotavirus Vaccines Sales Market Share by Type (2017-2028)
Figure 40. North America Rotavirus Vaccines Sales Market Share by Application (2017-2028)
Figure 41. North America Rotavirus Vaccines Sales Market Share by Country (2017-2028)
Figure 42. North America Rotavirus Vaccines Revenue Market Share by Country (2017-2028)
Figure 43. United States Rotavirus Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Rotavirus Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Rotavirus Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Rotavirus Vaccines Sales Market Share by Type (2017-2028)
Figure 47. Europe Rotavirus Vaccines Sales Market Share by Application (2017-2028)
Figure 48. Europe Rotavirus Vaccines Sales Market Share by Country (2017-2028)
Figure 49. Europe Rotavirus Vaccines Revenue Market Share by Country (2017-2028)
Figure 50. Germany Rotavirus Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Rotavirus Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Rotavirus Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Rotavirus Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Rotavirus Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Rotavirus Vaccines Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Rotavirus Vaccines Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Rotavirus Vaccines Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Rotavirus Vaccines Revenue Market Share by Region (2017-2028)
Figure 59. China Rotavirus Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Rotavirus Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Rotavirus Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Rotavirus Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Rotavirus Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Rotavirus Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Rotavirus Vaccines Sales Market Share by Type (2017-2028)
Figure 66. South America Rotavirus Vaccines Sales Market Share by Application (2017-2028)
Figure 67. South America Rotavirus Vaccines Sales Market Share by Country (2017-2028)
Figure 68. South America Rotavirus Vaccines Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Rotavirus Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Rotavirus Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Rotavirus Vaccines Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Rotavirus Vaccines Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Rotavirus Vaccines Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Rotavirus Vaccines Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Rotavirus Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Rotavirus Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Rotavirus Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Rotavirus Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Rotavirus Vaccines in 2021
Figure 80. Manufacturing Process Analysis of Rotavirus Vaccines
Figure 81. Rotavirus Vaccines Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
